Synbio Tech Inc. (TPEX:1295)
93.70
-1.20 (-1.26%)
At close: Dec 5, 2025
Synbio Tech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 302.33 | 469.39 | 346.74 | 226.28 |
Cash & Short-Term Investments | 302.33 | 469.39 | 346.74 | 226.28 |
Cash Growth | -22.85% | 35.37% | 53.23% | - |
Accounts Receivable | 79.55 | 112.06 | 111.27 | 84.09 |
Other Receivables | 1.24 | 0.83 | 1.88 | 2.95 |
Receivables | 80.8 | 112.89 | 113.14 | 87.05 |
Inventory | 259.1 | 163.49 | 147.93 | 155.9 |
Prepaid Expenses | - | - | 4.09 | 2.67 |
Restricted Cash | - | - | - | 190.18 |
Other Current Assets | 130.11 | 19.97 | 6.75 | 4.18 |
Total Current Assets | 772.34 | 765.73 | 618.64 | 666.27 |
Property, Plant & Equipment | 1,927 | 1,530 | 1,228 | 959.09 |
Other Intangible Assets | 20.83 | 23.73 | 19.12 | 23.22 |
Long-Term Deferred Tax Assets | 13.94 | 10.3 | 12.53 | 7.36 |
Other Long-Term Assets | 118.29 | 14.27 | 7.85 | 20.82 |
Total Assets | 2,852 | 2,345 | 1,886 | 1,677 |
Accounts Payable | 37.7 | 36.04 | 30.17 | 22.67 |
Accrued Expenses | - | - | 2.05 | 1.87 |
Short-Term Debt | 85 | - | - | 72.5 |
Current Portion of Long-Term Debt | 230.26 | 170.77 | 27.57 | 12.76 |
Current Portion of Leases | 2.28 | 2.29 | 2.5 | 3.44 |
Current Income Taxes Payable | 8.37 | 23.39 | 16.3 | 7.68 |
Current Unearned Revenue | 12.49 | 13.35 | 22.34 | 13.14 |
Other Current Liabilities | 152.58 | 165.36 | 98.35 | 88.42 |
Total Current Liabilities | 528.68 | 411.21 | 199.28 | 222.48 |
Long-Term Debt | 851.69 | 654.14 | 570.1 | 406.06 |
Long-Term Leases | 134.24 | 135.96 | 131.6 | 134.02 |
Long-Term Unearned Revenue | - | - | 29.89 | 16.14 |
Long-Term Deferred Tax Liabilities | 27.01 | 26.57 | 12.4 | 0.37 |
Other Long-Term Liabilities | 40.26 | 37.2 | - | - |
Total Liabilities | 1,582 | 1,265 | 943.27 | 779.07 |
Common Stock | 344.75 | 313.55 | 307.4 | 307.4 |
Additional Paid-In Capital | 402.17 | 250.66 | 256.81 | 256.81 |
Retained Earnings | 537.44 | 513.48 | 389.46 | 337.67 |
Comprehensive Income & Other | -14.2 | 1.74 | -10.7 | -4.2 |
Shareholders' Equity | 1,270 | 1,079 | 942.97 | 897.68 |
Total Liabilities & Equity | 2,852 | 2,345 | 1,886 | 1,677 |
Total Debt | 1,303 | 963.16 | 731.77 | 628.79 |
Net Cash (Debt) | -1,001 | -493.77 | -385.03 | -402.5 |
Net Cash Per Share | -30.71 | -15.67 | -12.22 | -12.78 |
Filing Date Shares Outstanding | 34.52 | 31.26 | 31.35 | 31.29 |
Total Common Shares Outstanding | 34.52 | 31.26 | 31.35 | 31.29 |
Working Capital | 243.66 | 354.52 | 419.36 | 443.78 |
Book Value Per Share | 36.79 | 34.53 | 30.07 | 28.69 |
Tangible Book Value | 1,249 | 1,056 | 923.85 | 874.47 |
Tangible Book Value Per Share | 36.19 | 33.77 | 29.46 | 27.95 |
Land | - | - | 11.6 | 11.6 |
Buildings | - | - | 431.73 | 433.59 |
Machinery | - | - | 532.03 | 501.77 |
Construction In Progress | - | - | 485.82 | 176.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.